Literature DB >> 9032457

Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

G Dimitriadis1, B Leighton, M Parry-Billings, S Sasson, M Young, U Krause, S Bevan, T Piva, G Wegener, E A Newsholme.   

Abstract

GENBANK/dy examines the mechanisms of glucocorticoid-induced insulin resistance in rat soleus muscle. Glucocorticoid excess was induced by administration of dexamethasone to rats for 5 days. Dexamethasone decreased the sensitivity of 3-O-methylglucose transport, 2-deoxyglucose phosphorylation, glycogen synthesis and glucose oxidation to insulin. The total content of GLUT4 glucose transporters was not decreased by dexamethasone; however, the increase in these transporters in the plasma membrane in response to insulin (100 m-units/litre) was lessened. In contrast, the sensitivity of lactate formation to insulin was normal. The content of 2-deoxyglucose in the dexamethasone-treated muscle was decreased at 100 m-units/litre insulin, while the contents of glucose 6-phosphate and fructose 2,6-bisphosphate were normal at all concentrations of insulin studied. The maximal activity of hexokinase in the soleus muscle was not affected by dexamethasone; however, inhibition of this enzyme by glucose 6-phosphate was decreased. These results suggest the following. (1) Glucocorticoid excess causes insulin resistance in skeletal muscle by directly inhibiting the translocation of the GLUT4 glucose transporters to the plasma membrane in response to insulin; since the activity of hexokinase is not affected, the changes in the sensitivity of glucose phosphorylation to insulin seen under these conditions are secondary to those in glucose transport. (2) The sensitivity of glycogen synthesis and glucose oxidation to insulin is decreased, but that of glycolysis is not affected: a redistribution of glucose away from the pathway of glycogen synthesis and glucose oxidation could maintain a normal rate of lactate formation although the rate of glucose transport is decreased.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032457      PMCID: PMC1218126          DOI: 10.1042/bj3210707

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Studies of tissue permeability. IX. The effect of insulin on the penetration of 3-methylglucose-H3 in frog muscle.

Authors:  H T NARAHARA; P OZAND
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

2.  Regulation of glucose uptake in muscle. VI. Effects of hypophysectomy, adrenalectomy, growth hormone, hydrocortisone, and insulin on glucose transport and phosphorylation in the perfused rat heart.

Authors:  H E MORGAN; D M REGEN; M J HENDERSON; T K SAWYER; C R PARK
Journal:  J Biol Chem       Date:  1961-08       Impact factor: 5.157

3.  Regulation of glucose uptake by muscle: functional significance of permeability and phosphorylating activity.

Authors:  D M KIPINIS
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

4.  Control of glycolysis in vertebrate skeletal muscle during exercise.

Authors:  U Krause; G Wegener
Journal:  Am J Physiol       Date:  1996-04

Review 5.  The glucose transporter family: structure, function and tissue-specific expression.

Authors:  G W Gould; G D Holman
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

6.  Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells.

Authors:  M Shetty; J N Loeb; K Vikstrom; F Ismail-Beigi
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

7.  Mechanisms of dexamethasone-induced insulin resistance in healthy humans.

Authors:  L Tappy; D Randin; P Vollenweider; L Vollenweider; N Paquot; U Scherrer; P Schneiter; P Nicod; E Jéquier
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

8.  Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle.

Authors:  G Dimitriadis; M Parry-Billings; B Leighton; T Piva; D Dunger; P Calder; J Bond; E Newsholme
Journal:  Eur J Clin Invest       Date:  1994-03       Impact factor: 4.686

9.  Effects of in-vivo administration of insulin-like growth factor-I on the rate of glucose utilization in the soleus muscle of the rat.

Authors:  G Dimitriadis; M Parry-Billings; D Dunger; S Bevan; A Colquhoun; A Taylor; P Calder; U Krause; G Wegener; E A Newsholme
Journal:  J Endocrinol       Date:  1992-04       Impact factor: 4.286

10.  Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.

Authors:  C Guillaume-Gentil; F Assimacopoulos-Jeannet; B Jeanrenaud
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

View more
  50 in total

Review 1.  Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!

Authors:  Vijay Srinivasan
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling.

Authors:  Taiyi Kuo; Michelle J Lew; Oleg Mayba; Charles A Harris; Terence P Speed; Jen-Chywan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 3.  Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome.

Authors:  P Putignano; F Pecori Giraldi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 4.  Stress hyperglycaemia.

Authors:  Kathleen M Dungan; Susan S Braithwaite; Jean-Charles Preiser
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

5.  Glucocorticoid-induced suppression of β-cell proliferation is mediated by Mig6.

Authors:  E Scott Colvin; Hong-Yun Ma; Yi-Chun Chen; Angelina M Hernandez; Patrick T Fueger
Journal:  Endocrinology       Date:  2013-02-05       Impact factor: 4.736

6.  How to manage hyperglycemia in an acute coronary syndrome patient.

Authors:  David Vivas; Esther Bernardo; Julian Palacios-Rubio; Antonio Fernández-Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02

7.  Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

Authors:  J Ruzzin; A S Wagman; J Jensen
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

8.  Effects of excess corticosterone on LKB1 and AMPK signaling in rat skeletal muscle.

Authors:  G Nathan Nakken; Daniel L Jacobs; David M Thomson; Natasha Fillmore; William W Winder
Journal:  J Appl Physiol (1985)       Date:  2009-12-03

Review 9.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

Review 10.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.